Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies

被引:40
作者
Calvert, AH [1 ]
Egorin, MJ [1 ]
机构
[1] Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
关键词
D O I
10.1016/S0959-8049(01)00340-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:11 / 16
页数:6
相关论文
共 52 条
[1]  
Ando M, 2000, CLIN CANCER RES, V6, P4733
[2]   Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing [J].
Ando, Y ;
Minami, H ;
Saka, H ;
Ando, M ;
Sakai, S ;
Shimokata, K .
BRITISH JOURNAL OF CANCER, 1997, 76 (08) :1067-1071
[3]   RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY [J].
BAJORIN, DF ;
SAROSDY, MF ;
PFISTER, DG ;
MAZUMDAR, M ;
MOTZER, RJ ;
SCHER, HI ;
GELLER, NL ;
FAIR, WR ;
HERR, H ;
SOGANI, P ;
SHEINFELD, J ;
RUSSO, P ;
VLAMIS, V ;
CAREY, R ;
VOGELZANG, NJ ;
CRAWFORD, ED ;
BOSL, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :598-606
[4]   Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer [J].
Belani, CP ;
Kearns, CM ;
Zuhowski, EG ;
Erkmen, K ;
Hiponia, D ;
Zacharski, D ;
Engstrom, C ;
Ramanathan, RK ;
Capozzoli, MJ ;
Aisner, J ;
Egorin, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :676-684
[5]  
CALVERT AH, 1995, SEMIN ONCOL, V22, P91
[6]   EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].
CALVERT, AH ;
HARLAND, SJ ;
NEWELL, DR ;
SIDDIK, ZH ;
JONES, AC ;
MCELWAIN, TJ ;
RAJU, S ;
WILTSHAW, E ;
SMITH, IE ;
BAKER, JM ;
PECKHAM, MJ ;
HARRAP, KR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147
[7]   CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].
CALVERT, AH ;
NEWELL, DR ;
GUMBRELL, LA ;
OREILLY, S ;
BURNELL, M ;
BOXALL, FE ;
SIDDIK, ZH ;
JUDSON, IR ;
GORE, ME ;
WILTSHAW, E .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756
[8]   PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL [J].
CALVERT, AH ;
HARLAND, SJ ;
NEWELL, DR ;
SIDDIK, ZH ;
HARRAP, KR .
CANCER TREATMENT REVIEWS, 1985, 12 :51-57
[9]  
Calvert AH, 1997, SEMIN ONCOL, V24, pS85
[10]  
Calvert AH, 1999, SEMIN ONCOL, V26, P90